Language
TW
Leadgene Leadgene
Murine RNase Inhibitor
Catalog Number

LDG0018RI

More Documents
Loading package & price...
  • Overview

    Description

    Murine RNase Inhibitor effectively inhibits various RNases (RNase A, B, C). Its superior antioxidant activity, due to the absence of two oxidation-sensitive cysteine residues found in human inhibitors, makes it ideal for DTT-sensitive experiments like qPCR. Additionally, it is free from DNase, RNase, and Nickase contaminants, ensuring RNA sample integrity.

  • Specifications
    • Expression System

      Escherichia coli

      Concentration

      40 U/μL

    • Storage Buffer

      20 mM HEPES-KOH, 50 mM KCl, 8 mM DTT, 50% glycerol, pH 7.6

      Purity

      >95% as determined by SDS-PAGE analysis.

    • Unit Definition

      One unit is defined as the amount of Murine RNase Inhibitor required to inhibit the activity of 5 ng of RNase A by 50%. Activity is measured by the inhibition of hydrolysis of cytidine 2', 3'-cyclic monophosphate by RNase A.

      Form

      Liquid

  • Instruction
    • Shipping

      The product is shipped with polar packs. Upon receipt, store it immediately at -20°C or lower for long term storage.

      Stability & Storage

      This product is stable after storage at:

      • 2-8°C for 2 weeks under sterile conditions from date of receipt.
      • -20°C or -80°C for 12 months under sterile conditions from date of receipt.

      Avoid repeated freeze/thaw cycles.
      Suggestion: Divide antibody into several vials. Keep only vials for usage at 2-8°C.

  • Review

    Help others learn more about this product. Use the link below to share your experience.

  • Publication

    There are currently no publications. Use the link below to let us know.

  • Datasheet & Documents
    MSDS
    Manual
    1
    /
    1

Disclaimer:For Research Use or Further Manufacturing Only.

This site uses cookies as described in our Privacy Policy in order to improve your user experience and deliver customized advertising to you. Click “I Agree” to consent and continue.